ABC | Volume 112, Nº5, May 2019

Guideline Brazilian Fetal Cardiology Guidelines – 2019 Arq Bras Cardiol. 2019; 112(5):600-648 Figure 7.3 – Sinus tachycardia clinical management. INVESTIGATE THE CAUSE IA SINUS TACHYCARDIA NO MORE CARDIOLOGICAL FOLLOW-UP NEEDED Figure 7.4 – Treatment flowchart for ventricular tachycardia. IV: intravenous; PO: orally. VENTRICULAR TACHYCARDIA WITH/WITHOUT HYDROPS AMIODARONE LOADING DOSE: 800–1200 mg PO MAINTENANCE DOSE: 200–600 mg/ day PO OR MATERNAL LIDOCAINE LOADING DOSE: 1–1.5 mg/kg IV and INFUSION: 1–4 mg/min REVERSED NOT REVERSED ELECTIVE BIRTH AT TERM WITH NEONATAL CARDIOLOGICAL FOLLOW- UP (DELIVERY AT THE FETAL CARDIOLOGY CENTER OR IN A TERTIARY HOSPITAL) IC HAS REACHED PULMONARY MATURITY HAS NOT REACHED PULMONARY MATURITY PREMATURE DELIVERY IN A TERTIARY HOSPITAL FOR NEONATAL CARDIOVERSION SECOND-LINE THERAPY SOTALOLPO 160–480 MG/DAY OR MAGNESIUM SULFATE: (MAXIMUM 48 HOURS) LOADING DOSE: 2–6 G IV 20 MIN FOLLOWED BY 1–2 G/H (MONITOR PATELLAR REFLEX) IC IC IIIC NOT REVERSED REVERSED WAIT FOR PULMONARY MATURITY PREMATURE DELIVERY IN A TERTIARY HOSPITAL FOR NEONATAL CARDIOVERSION 634